Feature | July 13, 2011

Varian’s Radiotherapy Delivery System Wins International Award for Product Design

July 13, 2011 – Varian's TrueBeam radiotherapy delivery system, a comprehensive re-design of linear accelerator technology, has won a top international design award. Launched last year, the sleek and fully integrated TrueBeam system has been selected for a prestigious Red Dot award for product design.

The Red Dot organization, based in Essen, Germany, awards prizes annually for product design, design agencies and design concepts. This year, designers and companies from 60 countries entered almost 4,500 products in the Red Dot award for product design and the winners were announced at an awards ceremony in Essen. More information about the awards and a list of winners can be found at www.red-dot.org.

"As always, our jury cast a very careful eye over the products submitted," said Professor Peter Zec, M.D., the initiator of the Red Dot design award. "Design quality has asserted itself clearly in the judging process, with genuine and new creative solutions also being rewarded. Both of these criteria are not just yardsticks for good design, but also for the potential for success on the market."

TrueBeam was developed to treat tumors in a fast and precise manner, including tumors that move during treatment as the patient breathes in and out. Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, TrueBeam features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management and treatment delivery. The system was engineered by Varian's development team, with industrial design executed in collaboration with the BMW Group DesignWorksUSA.

TrueBeam can quickly and precisely deliver a broad range of radiotherapy treatments, from stereotactic radiosurgery and stereotactic body radiotherapy to image-guided intensity modulated and volumetric radiotherapy treatments. With its High Intensity Mode, TrueBeam can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology. Since its launch in April 2010, Varian has taken orders for over 220 TrueBeam systems, while more than 65 installations are complete or in progress in all parts of the world.

For more information: www.varian.com

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...